Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma von IWAMOTO, F. M, ABREY, L. E, BEAL, K, GUTIN, P. H, ROSENBLUM, M. K, REUTER, V. E, DEANGELIS, L. M, LASSMAN, A. B

Volltext

Primary CNS lymphoma with intraocular involvement : International PCNSL Collaborative Group Report von GRIMM, S. A, MCCANNEL, C. A, HALL, A. J, GRAUS, F, HERRLINGER, U, SCHIFF, D, RAIZER, J, RUBENSTEIN, J, LAPERRIERE, N, THIEL, E, DOOLITTLE, N, IWAMOTO, F. M, OMURO, A. M. P, ABREY, L. E, FERRERI, A. J. M, BLAY, J.-Y, NEUWELT, E. A, SIEGAL, T, BATCHELOR, T, JAHNKE, K, SHENKIER, T. N

Volltext

Semiautomated volumetric measurement on postcontrast MR imaging for analysis of recurrent and residual disease in glioblastoma multiforme von Chow, D S, Qi, J, Guo, X, Miloushev, V Z, Iwamoto, F M, Bruce, J N, Lassman, A B, Schwartz, L H, Lignelli, A, Zhao, B, Filippi, C G

Volltext

Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome von LEHKY, T. J, IWAMOTO, F. M, KREISL, T. N, FLOETER, M. K, FINE, H. A

Volltext

Results of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM) von Peereboom, D., Nabors, L.B., Kumthekar, P., Badruddoja, M., Fink, K., Lieberman, F., Phuphanich, S., Dunbar, E., Walbert, T., Schiff, D., Tran, D.D., Ashby, L.S., Butowski, N., Iwamoto, F., Lindsay, R., Bullington, J., Schulder, M., Sherman, J., Brooks, C., Reardon, D.

Volltext

Extended cell and plasma drug levels after one dose of a three-in-one nanosuspension containing lopinavir, efavirenz, and tenofovir in nonhuman primates von Koehn, Josefin, Iwamoto, Jennifer F, Kraft, John C, McConnachie, Lisa A, Collier, Ann C, Ho, Rodney J.Y

Volltext

Extreme ultraviolet lithography at IMEC: Shadowing compensation and flare mitigation strategy von Lorusso, G. F., Goethals, A. M., Jonckheere, R., Hermans, J., Ronse, K., Myers, A. M., Kim, I., Niroomand, A., Iwamoto, F., Ritter, D.

Volltext

OS09.5 Synergistic effect of reirradiation and PD-1 inhibitors in recurrent high-grade gliomas von Iwamoto, F. M., Donovan, L.

Volltext

Isolation of freeze-tolerant laboratory strains of Saccharomyces cerevisiae from proline-analogue-resistant mutants von Takagi, H, Iwamoto, F, Nakamori, S

Volltext

Fungal encephalitis following bone marrow transplantation: Clinical findings and prognosis von Teive, HAG, Carsten, ALM, Iwamoto, FM, Almeida, SM, Munhoz, RP, Werneck, LC, Medeiros, CR, Pasquini, R

Volltext

MGMT Promoter Methylation Predicts Survival in 1p19q-Codeleted Gliomas after Chemotherapy von Kinslow, C.J., Rae, A., Kumar, P., Grinband, J., Gill, B.J.A., McKhann, G.M., Sisti, M.B., Bruce, J.N., Canoll, P., Iwamoto, F., Yu, J.B., Kachnic, L.A., Cheng, S.K., Wang, T.J.C.

Volltext

Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas von Iwamoto, F. M., Hottinger, A. F., Karimi, S., Riedel, E., Dantis, J., Jahdi, M., Panageas, K. S., Lassman, A. B., Abrey, L. E., Fleisher, M., DeAngelis, L. M., Holland, E. C., Hormigo, A.

Volltext

Clinical Endpoints Correlation with Molecular Features in the NRG Oncology/RTOG 9802 Low-Grade Glioma, Low-Risk Observation Arm von Fleming, J.L., Iwamoto, F., Polley, M.Y., Shaw, E.G., Buckner, J., Barger, G.R., Ricci, P.E., Gilbert, M., Bullard, D.E., Brown, P.D., Stelzer, K.J., McElroy, J., Becker, A., Rogers, L., Russo, G.A., Straza, M.W., Huang, J., Won, M., Mehta, M.P., Chakravarti, A.

Volltext

Effect of Molecular Classification on Glioma Outcomes in Hispanic Patients von Ishak, E.M., Mercurio, A., Kinslow, C.J., Siegelin, M., McKhann, G.M., Gallitto, M., Sisti, M.B., Bruce, J.N., Canoll, P., Iwamoto, F., Horowitz, D.P., Neugut, A.I., Kachnic, L.A., Cheng, S.K., Wang, T.J.C.

Volltext

Association of Age with IDH-Status and Progression in Diffuse Gliomas von Kinslow, C.J., Mercurio, A., Kumar, P., Siegelin, M., Kocakavuk, E., McKhann, G.M., Sisti, M.B., Bruce, J.N., Canoll, P., Iwamoto, F., Horowitz, D.P., Neugut, A.I., Kachnic, L.A., Brown, P.D., Cheng, S.K., Wang, T.J.C.

Volltext

P11.82.A TARGETING THE GLIOBLASTOMA MASTER REGULATOR C/EBPß: A PHARMACOKINETIC AND PHARMACODYNAMIC NEOADJUVANT STUDY OF ST101 von Iwamoto, F, Al Dalahmah, O, Manjrekar, K, Levrero, C, Michel, R, Bargo, A, Kaesshaefer, S, Butowski, N, Peters, K, Buerki, R, Bexon, A, Vainstein-Haras, A

Volltext

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02) von Iwamoto, Fabio M., Lamborn, Kathleen R., Robins, H. Ian, Mehta, Minesh P., Chang, Susan M., Butowski, Nicholas A., DeAngelis, Lisa M., Abrey, Lauren E., Zhang, Wei-Ting, Prados, Michael D., Fine, Howard A.

Volltext

A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma von Kreisl, Teri N., Zhang, Weiting, Odia, Yazmin, Shih, Joanna H., Butman, John A., Hammoud, Dima, Iwamoto, Fabio M., Sul, Joohee, Fine, Howard A.

Volltext

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors von Lassman, Andrew B., Iwamoto, Fabio M., Cloughesy, Timothy F., Aldape, Kenneth D., Rivera, Andreana L., Eichler, April F., Louis, David N., Paleologos, Nina A., Fisher, Barbara J., Ashby, Lynn S., Cairncross, J. Gregory, Roldán, Gloria B., Wen, Patrick Y., Ligon, Keith L., Schiff, David, Robins, H. Ian, Rocque, Brandon G., Chamberlain, Marc C., Mason, Warren P., Weaver, Susan A., Green, Richard M., Kamar, Francois G., Abrey, Lauren E., DeAngelis, Lisa M., Jhanwar, Suresh C., Rosenblum, Marc K., Panageas, Katherine S.

Volltext

A phase I/II trial of vandetanib for patients with recurrent malignant glioma von Kreisl, Teri N, McNeill, Katharine A, Sul, Joohee, Iwamoto, Fabio M, Shih, Joanna, Fine, Howard A

Volltext